| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/20/2013 | CN102973947A Antibody-drug conjugates and methods |
| 03/20/2013 | CN102973939A IgY antibody preparation having mixed specificity for resistance to streptococcus mutans and streptococcus sobrinus, and preparation method and IgY total toothpaste |
| 03/20/2013 | CN102277333B Monoclonal antibody resisting foot and mouth disease virus, epitope identified by monoclonal antibody, as well as application of monoclonal antibody |
| 03/20/2013 | CN102260347B Synthesis and application method of antigen for multiple heavy metals |
| 03/20/2013 | CN102180967B Method for extracting immunoglobulin A (IgA) of Przewalski's horse noninvasively |
| 03/20/2013 | CN102174475B Preparation and application of hIL-17RD-ECD monoclonal antibody |
| 03/20/2013 | CN102154216B Anti-creatine kinase M (CKM) monoclonal antibody, hybridoma cell line producing same and use thereof |
| 03/20/2013 | CN101979511B Heavy metal zinc-resistant monoclonal antibody |
| 03/20/2013 | CN101955537B Anti-ractopamine antibody and application thereof |
| 03/20/2013 | CN101955536B Anti-sulfonamides antibody and application thereof |
| 03/20/2013 | CN101955535B Gentamicin antibody and application thereof |
| 03/20/2013 | CN101704890B Preparation method of duck hepatitis antibody |
| 03/20/2013 | CN101619305B Antihuman CD52 monoclonal antibody hybridoma cell line, monoclonal antibody, engineered antibody, carrier, reagent kit and application thereof |
| 03/20/2013 | CN101611057B Antibody molecules for human il-17 |
| 03/20/2013 | CN101522716B High affinity human antibodies to human IL-4 receptor |
| 03/20/2013 | CN101522715B Monoclonal antibody to soluble lox-1 |
| 03/20/2013 | CN101426936B Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
| 03/20/2013 | CN101142236B Adam-9调节剂 Adam-9 modifiers |
| 03/19/2013 | US8401799 Antibody design using anti-lipid antibody crystal structures |
| 03/19/2013 | US8399653 Transferrin/transferrin receptor-mediated siRNA delivery |
| 03/19/2013 | US8399650 Mycobacterial antigens expressed during latency |
| 03/19/2013 | US8399630 Engineered anti-IL-13 antibodies, compositions, methods and uses |
| 03/19/2013 | US8399628 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 03/19/2013 | US8399627 Antibodies to TNFα |
| 03/19/2013 | US8399626 Antibodies against human angiopoietin 2 |
| 03/19/2013 | US8399623 Human antibodies that bind mesothelin, and uses thereof |
| 03/19/2013 | US8399622 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 03/19/2013 | US8399621 Anti-CD4 antibody |
| 03/19/2013 | US8399618 Immunoglobulin insertions, deletions, and substitutions |
| 03/19/2013 | US8399617 Non-functional P2X7 receptor |
| 03/19/2013 | US8399384 Focused libraries of genetic packages |
| 03/19/2013 | US8399250 Anti-mpl ligand (thromobpoietin) antibodies |
| 03/19/2013 | US8399207 Monoclonal antibodies against osteopontin |
| 03/19/2013 | US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same |
| 03/19/2013 | US8399200 Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | US8398996 Staphylococcus aureus proteins and nucleic acids |
| 03/19/2013 | US8398990 Glucan-based vaccines |
| 03/19/2013 | US8398986 ADP-ribosylating toxin from listeria monocytogenes |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/19/2013 | US8398982 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2013 | US8398980 Subtypes of humanized antibody against interleuken-6 receptor |
| 03/19/2013 | US8398975 Antibodies directed to αVβ6 and uses thereof |
| 03/19/2013 | US8398966 IL-1 binding proteins |
| 03/19/2013 | CA2551905C Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 03/19/2013 | CA2536086C Inhibition of dr3 in the treatment of allergic lung inflammation |
| 03/19/2013 | CA2497364C Protein purification method |
| 03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
| 03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 03/14/2013 | WO2013036755A1 Etv1 antibodies and uses thereof |
| 03/14/2013 | WO2013036130A1 Broadly neutralizing vhh against hiv-1 |
| 03/14/2013 | WO2013036101A1 Rubber allergenic proteins and immunoassay derived thereof |
| 03/14/2013 | WO2013035824A1 Cancer stem cell isolation |
| 03/14/2013 | WO2013035799A1 Antibody capable of binding to specific region of periostin, and method for measuring periostin using same |
| 03/14/2013 | WO2013035345A2 Dengue-virus serotype neutralizing antibodies |
| 03/14/2013 | WO2013035208A1 ANTIBODY AGAINST MUTANT α-ACTININ-4 |
| 03/14/2013 | WO2013034933A1 Anti ddr1 antibodies, their uses and methods identifying them |
| 03/14/2013 | WO2013034904A1 Anti-cd40 antibodies, uses and methods |
| 03/14/2013 | WO2013034900A1 Caninised antibodies and method for the production of same |
| 03/14/2013 | WO2013034736A1 Use of staphylococcal superantigen- like 3 (ssl3) as an tlr2 inhibitor |
| 03/14/2013 | WO2013034682A1 Vaccine based on staphylococcal superantigen- line 3 protein (ssl3) |
| 03/14/2013 | WO2013034660A1 Anti-siglec-15 antibodies and uses thereof |
| 03/14/2013 | WO2013013075A3 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 03/14/2013 | WO2012170842A3 Peptide for protection of allergic respiratory disorders |
| 03/14/2013 | WO2012168344A8 BINDING COMPOUNDS TO HUMAN β1-ADRENORECEPTOR (β1-AR) AND THEIR USE IN THE MEASUREMENT OF AUTO-ANTI-βA1-AR ANTIBODIES |
| 03/14/2013 | WO2012153186A3 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells |
| 03/14/2013 | WO2012149562A3 Selective anti-hla antibody removal device and methods of production and use thereof |
| 03/14/2013 | WO2012149356A3 Anti-cd40 antibodies and methods of use |
| 03/14/2013 | WO2012145183A3 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer |
| 03/14/2013 | WO2012139086A3 Single chain antibodies for photosynthetic microorganisms and methods of use |
| 03/14/2013 | WO2012135854A3 T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 |
| 03/14/2013 | WO2012123949A8 Bi- and monospecific, asymmetric antibodies and methods of generating the same |
| 03/14/2013 | WO2012120535A3 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same |
| 03/14/2013 | WO2012118903A3 Sclerostin and dkk-1 bispecific binding agents |
| 03/14/2013 | WO2012052074A3 Novel biomarkers of liver cancer |
| 03/14/2013 | WO2012012750A8 Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery |
| 03/14/2013 | US20130067608 Colon cancer targets and uses thereof |
| 03/14/2013 | US20130066252 Method for diagnosis for multiple sclerosis involving anti1-receptor antibody |
| 03/14/2013 | US20130066054 Multivalent antibodies |
| 03/14/2013 | US20130066053 Detection of Synthetic Cannabinoids |
| 03/14/2013 | US20130066052 Ucp4 |
| 03/14/2013 | US20130066051 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 03/14/2013 | US20130065945 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof |
| 03/14/2013 | US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv |
| 03/14/2013 | US20130065775 Methods for diagnosing skin diseases |
| 03/14/2013 | US20130065323 Detection of Synthetic Cannabinoids |
| 03/14/2013 | US20130065254 Novel epigenetic mechanisms related to dna damage and aging |
| 03/14/2013 | US20130065238 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 03/14/2013 | US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 03/14/2013 | US20130064851 Inactivated staphylococcal whole-cell vaccine |
| 03/14/2013 | US20130064840 Hjurp peptides and vaccines including the same |
| 03/14/2013 | US20130064838 Enhanced death receptor agonists |
| 03/14/2013 | US20130064837 Integrin alpha-v beta8 neutralizing antibody |
| 03/14/2013 | US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 03/14/2013 | US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 03/14/2013 | US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof |
| 03/14/2013 | US20130064826 Anti-emr1 antibodies |
| 03/14/2013 | US20130064823 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |